Reports Q1 fiscal 2027 results for quarter ended June 30
Shows how much money the company made and spent during the three-month period.
Prestige Consumer Healthcare Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Shows how much money the company made and spent during the three-month period.
Company shared earnings news and presentation slides with people who own or follow the stock.
Company borrowed money by selling debt that pays 6.250% interest yearly until July 2034.
Company obtained loan to help buy Australian skin care brands for approximately $150 million.
Company borrowed over $1 billion to pay for major transactions happening on June 12, 2026.
Shows company's total revenue, expenses and profits for the twelve-month period ended March 31, 2026.
Company will buy Australian therapeutic skin care brands to expand its product offerings internationally.
Stocky reads Prestige Consumer Healthcare Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Prestige Consumer Healthcare Inc.'s most recent tracked filing was a 10-Q on 6 Aug 2026: Reports Q1 fiscal 2027 results for quarter ended June 30.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.